Cargando…

Identification of p38 beta as a therapeutic target for the treatment of Sézary Syndrome

Cutaneous T-Cell Lymphomas (CTCL) represent a group of hematopoietic malignancies that home to the skin and have no known molecular basis for disease pathogenesis. Sézary syndrome (SS) is the leukemic variant of CTCL. Currently, CTCL is incurable, highlighting the need for new therapeutic modalities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bliss-Moreau, Meghan, Coarfa, Cristian, Gunaratne, Preethi H, Guitart, Joan, Krett, Nancy L, Rosen, Steven T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289446/ https://www.ncbi.nlm.nih.gov/pubmed/25148579 http://dx.doi.org/10.1038/jid.2014.367

Ejemplares similares

Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma
por: Thomas, Alexandra L., et al.
Publicado: (2015)

Chromatin Changes in Dicer-Deficient Mouse Embryonic Stem Cells in Response to Retinoic Acid Induced Differentiation
por: Tennakoon, Jayantha B., et al.
Publicado: (2013)

The Repertoire and Features of Human Platelet microRNAs
por: Plé, Hélène, et al.
Publicado: (2012)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Plantar keratoderma of Sézary syndrome
por: Fragkos, Konstantinos C.
Publicado: (2017)

Mycosis fungoides and Sézary syndrome
por: Jonak, Constanze, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome
por: Lee, Hyewon
Publicado: (2023)

Dupilumab-Associated Sezary Syndrome
por: Hamp, Austin, et al.
Publicado: (2023)

MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019)

Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
por: Oka, Tomonori, et al.
Publicado: (2019)

Analysis of MicroRNA Expression in the Prepubertal Testis
por: Buchold, Gregory M., et al.
Publicado: (2010)

Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma
por: Cheng, Javelin C, et al.
Publicado: (2013)

Inhibition of Glycogen Synthase Kinase 3 (GSK3) Increases the Cytotoxicity of Enzastaurin
por: Rovedo, Mark, et al.
Publicado: (2011)

Integrated Genomic Analysis of Sézary Syndrome
por: Mao, Xin, et al.
Publicado: (2011)

A mouse model for the Sézary syndrome
por: Doebbeling, Udo
Publicado: (2010)

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome
por: Moerman-Herzog, Andrea, et al.
Publicado: (2020)

The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications
por: Pileri, Alessandro, et al.
Publicado: (2021)

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management
por: Miyashiro, Denis, et al.
Publicado: (2023)

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
por: Bhardwaj, Anjana, et al.
Publicado: (2015)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
por: Miyashiro, Denis, et al.
Publicado: (2022)

TOX Expression in Mycosis Fungoides and Sezary Syndrome
por: Pileri, Alessandro, et al.
Publicado: (2022)

CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
por: Quaglino, Pietro, et al.
Publicado: (2022)

Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome
por: Beylot‐Barry, Marie, et al.
Publicado: (2022)

Ronin Governs Early Heart Development by Controlling Core Gene Expression Programs
por: Fujita, Jun, et al.
Publicado: (2017)

Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2017)

EPHA4 is overexpressed but not functionally active in Sézary syndrome
por: Hameetman, Liesbeth, et al.
Publicado: (2015)

New Insights Into the Complex Mutational Landscape of Sézary Syndrome
por: Mirza, Abu-Sayeef, et al.
Publicado: (2020)

The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome
por: Liu, Zhaorui, et al.
Publicado: (2021)

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
por: Robertson, Jake C, et al.
Publicado: (2021)

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
por: Dobos, Gabor, et al.
Publicado: (2023)

P38 kinase in gastrointestinal cancers
por: Phan, Thuy, et al.
Publicado: (2023)

An integrative transcriptomic approach to identify depot differences in genes and microRNAs in adipose tissues from high fat fed mice
por: Wijayatunga, Nadeeja N., et al.
Publicado: (2018)

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)
por: Levy, Ilana, et al.
Publicado: (2023)

Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
por: Karadağ, Yeşim S., et al.
Publicado: (2013)

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
por: Vural, Seçil, et al.
Publicado: (2018)

Double-positive CD4 and CD8 Sézary syndrome
por: Miyashiro, Denis, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_egu3lnm1ttuem57kffc2k0l7p5